An official website of the United States government
Home
Name
SR48692
Alternate Names
SR 48692
SR-48692
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytotoxic neurotensin antagonist
NSC Number
None
Primary Site
Pancreatic
prostate cancer
Histology
None
Remarks
Phase II Neurotensin (NT) receptor antagonist. Sanofi-Synthelabo.
Coding
This drug should be coded
